π Big news! #TargetRWE is proud to announce our acquisition by Highlander Health, led by industry trailblazers Dr. Amy Abernethy and Dr. Brad Hirsch, aimed to modernize #ClinicalEvidence generation & improve personalized care for patients.
Link π bwnews.pr/40lousZ
ππ Check out #TargetRWEβs latest study on #HCC patients! πππ-ππππ explores the risk of HCC recurrence after Direct-Acting Antiviral (DAA) therapy. The study shows DAA doesnβt increase recurrence risk in patients with a prior complete response: onlinelibrary.wiley.com/doi/β¦
π₯π Missed #TargetRWE's #ACG2024 research? Watch Dr. Evan S. Dellon, MD, MPH, dive into our study on Eosinophilic Esophagitis (EoE) treatment patterns. He explores why some diagnosed patients aren't receiving medication. Donβt miss these key insights: targetrwe.com/research/news/β¦
Today, on #InternationalWomensDay, we celebrate the incredible contributions of women in #hepatology. From pioneering research to patient care, their dedication is shaping the future of #liver health. #IWD2025
At #ACG2024, Dr. A. Sidney Barritt IV from #TargetRWE presented on SGLT2i & DPP4i for metabolic dysfunction-associated steatohepatitis (MASH) π§ββοΈπ. π Explore their potential benefits in #MASH management. Watch the presentation here: bit.ly/430KriB#SGLT2i#DPP4i
High-energy week at #TargetRWE! π We had a fantastic all-hands meeting hosted by Highlander Health. From insightful discussions to a mini-hackathon, we tackled key challenges and aligned on critical objectives.
Thanks to everyone for their contributions! #RealWorldEvidence